With deepest regret ESCOP had to accept the message that Prof. em. Otto Sticher has passed away on March 11th, 2022, at the age of 85. Since some decades, Prof. em. Sticher had served as a supervising editor for ESCOP, checking the final versions of all ESCOP monographs as one of the most … [Read more...] about In memoriam Otto Sticher (1936-2022)
News
Obituary Luc von Hebel (1934–2022)
It is with great sadness to learn recently that Luc von Hebel, another founding father of ESCOP, has passed away on February 22nd, 2022, at the age of 88. As a member of the Netherlands Association for Phytotherapy (Nederlandse Vereniging voor Fytotherapie, NVF), he was not only … [Read more...] about Obituary Luc von Hebel (1934–2022)
eSymposium Phytotherapeutics in Children
Online - 17 May, 2022, 10.00 PM to 5.00 PM (CEST) Rationalizing optimal Dosing for use in Children: Current Situation – Potential Solutions – Activities needed Science for Children at the border between paediatrics, regulatory affairs “Children are no small adults with respect to the treatment … [Read more...] about eSymposium Phytotherapeutics in Children
Webinar: Cranberry, an example of ESCOP monographs
25/3/2021, 16:00-17:00 h (CET) Program: 16:00-16:05 h. Presentation of ESCOP. Dr. Tankred Wegener (Chaiman of ESCOP). 16:05-16:40 h. Lecture: Cranberry, an example of ESCOP monographs. Prof. Dr. Liselotte Krenn, Department of Pharmacognosy, University of Vienna (Austria). Deputy Chair and … [Read more...] about Webinar: Cranberry, an example of ESCOP monographs
Ashwagandha root may improve sleep quality and can help in managing insomnia
Ashwagandha (Withania somnifera (L.) Dunal) is a traditional Indian medicinal plant used for several purposes, including the alleviation of sleep disturbances. Although the long-standing tradition supports its efficacy, modern clinical data are scarce. A recent randomized, placebo-controlled … [Read more...] about Ashwagandha root may improve sleep quality and can help in managing insomnia
Herbal drugs as possible adjuvant symptomatic therapy in COVID-19
A recent study investigated available data to provide a benefit/risk assessment for a use of herbal medicines, which are traditionally indicated for respiratory diseases, as adjuvant symptomatic therapy in the self-management of mild symptoms in the context of COVID-19 disease. Thirty-nine herbal … [Read more...] about Herbal drugs as possible adjuvant symptomatic therapy in COVID-19